Evidence map›Paper›PMID 25066711›Full record

ArticleFuture oncology (London, England)2015

Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.

Luciane Tsukamoto Kagohara, Juliana L Schussel, Tejaswini Subbannayya, Nandini Sahasrabuddhe, Cynthia Lebron, Mariana Brait, Leonel Maldonado, Blanca L Valle, Francesca Pirini, Martha Jahuira and 8 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Future oncology (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Promoter hypermethylation ofClinical epigenetics · 2016
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 5 countries.

Luciane Tsukamoto KagoharaDepartment of Otolaryngology-Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Juliana L Schussel
Tejaswini Subbannayya
Nandini Sahasrabuddhe
Cynthia Lebron
Mariana Brait
Leonel Maldonado
Blanca L Valle
Francesca Pirini
Martha Jahuira
Jaime Lopez
Pablo Letelier
Priscilla Brebi-Mieville
Carmen Ili
Akhilesh Pandey
Aditi Chatterjee
David Sidransky
Rafael Guerrero-Preston
Johns Hopkins University · USJohns Hopkins Medicine · USInstitute of Bioinformatics · INUniversidad de La Frontera · CLTemuco Catholic University · CLUniversidade Federal do Paraná · BR

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
INTEGRATED DEVELOPMENT OF NOVEL MOLECULAR MARKERSU01CA084986 · NCI · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 1999 to 2014
$33.8M
TUMOR SUPPRESOR GENE PROMOTER HYPERMETHYLATION FOR DETECTION OF HEAD AND NECKP50DE019032 · NIDCR · JOHNS HOPKINS UNIVERSITY · PI SIDRANSKY, DAVID · 2007 to 2016
$27.1M
Proteome Characterization Center: A Genoproteomics Pipeline for Cance ResearchU24CA160036 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2011 to 2016
$10.7M
Epigenomic Markers of HNSCC Survival Across Ethnic GroupsK01CA164092 · NCI · JOHNS HOPKINS UNIVERSITY · PI GUERRERO-PRESTON, RAFAEL · 2011 to 2014
$530k
NCI NIH HHS K01 CA164092NCI NIH HHS K01CA164092NCI NIH HHS P30 CA006973NCI NIH HHS U01 CA084986NCI NIH HHS U01CA84986NCI NIH HHS U24 CA160036NCI NIH HHS U24CA160036NIDCR NIH HHS P50 DE019032
6 · The paper itself

Abstract

aimThe aim of the study was to evaluate the use of global and gene-specific DNA methylation changes as potential biomarkers for gallbladder cancer (GBC) in a cohort from Chile. MATERIAL &

methodsDNA methylation was analyzed through an ELISA-based technique and quantitative methylation-specific PCR.

resultsGlobal DNA Methylation Index (p = 0.02) and promoter methylation of SSBP2 (p = 0.01) and ESR1 (p = 0.05) were significantly different in GBC when compared with cholecystitis. Receiver curve operator analysis revealed promoter methylation of APC, CDKN2A, ESR1, PGP9.5 and SSBP2, together with the Global DNA Methylation Index, had 71% sensitivity, 95% specificity, a 0.97 area under the curve and a positive predictive value of 90%.

conclusionGlobal and gene-specific DNA methylation may be useful biomarkers for GBC clinical assessment.

Indexed as

DNA MethylationAdultAgedAged, 80 and overCell Line, TumorChileCholecystitisFemaleGallbladder NeoplasmsHumansMaleMiddle AgedMolecular Diagnostic TechniquesPromoter Regions, GeneticROC CurveSequence Analysis, DNAgallbladder cancerglobal and gene-specific DNA methylationmolecular biomarkers paneltumor suppressor genes

Identifiers

PMID25066711
PMCPMC4332836
OpenAlexW2100316134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.